COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation

BACKGROUND & AIMS: Studies have shown decreased response to coronavirus disease 2019 (COVID-19) vaccinations in some populations. In addition, it is possible that vaccine-triggered immune activation could trigger immune dysregulation and thus exacerbate inflammatory bowel diseases (IBD). In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Lev-Tzion, Raffi, Focht, Gili, Lujan, Rona, Mendelovici, Adi, Friss, Chagit, Greenfeld, Shira, Kariv, Revital, Ben-Tov, Amir, Matz, Eran, Nevo, Daniel, Barak-Corren, Yuval, Dotan, Iris, Turner, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697416/
https://www.ncbi.nlm.nih.gov/pubmed/34954338
http://dx.doi.org/10.1016/j.cgh.2021.12.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697416/
https://www.ncbi.nlm.nih.gov/pubmed/34954338
http://dx.doi.org/10.1016/j.cgh.2021.12.026

Ejemplares similares